Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Saarbrücken – page 2

46 clinical trials in Saarbrücken, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Saarbrücken at a glance
46
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

46 trials in Saarbrücken

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Universitaet Des Saarlandes
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Medical Center - University Of Freiburg
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Sutro Biopharma Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Celcuity Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:BioNTech SE
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Adenocarcinoma gastric+3

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Astellas Pharma Global Development Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Saarbrücken

What the registry says about research in the country

01 Breast Cancer Research

Extensive clinical trials focusing on hormone receptor-positive and triple-negative breast cancer treatments. Studies evaluate novel therapeutic combinations and targeted approaches for different breast cancer subtypes.

  • Advanced treatment strategies with CDK4/6 inhibitors
  • Immunotherapy applications
  • Targeted therapies for specific mutations

Multiple innovative approaches are being tested to improve patient outcomes across various stages of breast cancer.

02 Gastrointestinal Oncology

Research focused on colorectal cancer, gastric cancer, and advanced digestive system malignancies. Studies explore preoperative treatments and novel therapeutic combinations.

  • Preoperative chemotherapy protocols
  • Advanced stage treatment strategies
  • Targeted therapeutic approaches

Trials aim to improve surgical outcomes and survival rates in gastrointestinal cancers.

03 Hematologic Malignancies

Studies investigating treatments for chronic lymphocytic leukemia, multiple myeloma, and Hodgkin lymphoma. Research focuses on combination therapies and novel treatment approaches.

  • Innovative drug combinations
  • Targeted therapies for specific mutations
  • Treatment optimization studies

Trials evaluate effectiveness of various therapeutic combinations and treatment durations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.